Literature DB >> 2666307

Acute inflammatory effects of a monocyte-derived neutrophil-activating peptide in rabbit skin.

S J Foster1, D M Aked, J M Schröder, E Christophers.   

Abstract

The inflammatory effects of a monocyte-derived neutrophil-activating peptide (MONAP), purified to homogeneity from lipopolysaccharide-stimulated human peripheral blood monocytes, have been evaluated in rabbit skin. Intradermal injection of MONAP alone caused a mild infiltration of polymorphonuclear leucocytes (PMNL) but did not induce any change in plasma extravasation. When combined with prostaglandin E2(PGE2), MONAP caused a marked and synergistic increase in PMNL infiltration and plasma extravasation into the injected skin sites. The increase in vascular permeability induced by MONAP depended on the presence of circulating PMNL. MONAP is a novel cytokine with pro-inflammatory properties and may have physiological and pathophysiological roles in health and disease.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2666307      PMCID： PMC1385254     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


  12 in total

1.  Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity.

Authors:  J M Schröder; U Mrowietz; E Morita; E Christophers
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

2.  Control of vascular permeability by polymorphonuclear leukocytes in inflammation.

Authors:  C V Wedmore; T J Williams
Journal:  Nature       Date:  1981-02-19       Impact factor: 49.962

3.  Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes.

Authors:  A Walz; P Peveri; H Aschauer; M Baggiolini
Journal:  Biochem Biophys Res Commun       Date:  1987-12-16       Impact factor: 3.575

4.  Identification of C5ades arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales.

Authors:  J M Schröder; E Christophers
Journal:  J Invest Dermatol       Date:  1986-07       Impact factor: 8.551

5.  Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation.

Authors:  T J Williams
Journal:  Br J Pharmacol       Date:  1979-03       Impact factor: 8.739

6.  Structure determination of a human lymphocyte derived neutrophil activating peptide (LYNAP).

Authors:  H Gregory; J Young; J M Schröder; U Mrowietz; E Christophers
Journal:  Biochem Biophys Res Commun       Date:  1988-03-15       Impact factor: 3.575

7.  Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells.

Authors:  T A Luger; J A Charon; M Colot; M Micksche; J J Oppenheim
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

8.  Purification and partial biologic characterization of a human lymphocyte-derived peptide with potent neutrophil-stimulating activity.

Authors:  J M Schröder; U Mrowietz; E Christophers
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

9.  Evidence that neutrophil accumulation induced by interleukin-1 requires both local protein biosynthesis and neutrophil CD18 antigen expression in vivo.

Authors:  M Rampart; T J Williams
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

10.  A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity.

Authors:  J Van Damme; J Van Beeumen; G Opdenakker; A Billiau
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307
View more
  13 in total

1.  A major role for neutrophils in experimental bullous pemphigoid.

Authors:  Z Liu; G J Giudice; X Zhou; S J Swartz; J L Troy; J A Fairley; G O Till; L A Diaz
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Systemic neutralization of interleukin-8 markedly reduces neutrophilic pleocytosis during experimental lipopolysaccharide-induced meningitis in rabbits.

Authors:  R A Dumont; B D Car; N N Voitenok; U Junker; B Moser; O Zak; T O'Reilly
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Peptide inhibitor of interleukin-8 (IL-8) reduces staphylococcal enterotoxin-A (SEA) induced neutrophil trafficking to the lung.

Authors:  E J Miller; A B Cohen; B T Peterson
Journal:  Inflamm Res       Date:  1996-08       Impact factor: 4.575

4.  Antibiotic-induced cell wall fragments of Staphylococcus aureus increase endothelial chemokine secretion and adhesiveness for granulocytes.

Authors:  P van Langevelde; E Ravensbergen; P Grashoff; H Beekhuizen; P H Groeneveld; J T van Dissel
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

5.  Identification of oligopeptide sequences which inhibit migration induced by a wide range of chemokines.

Authors:  J Reckless; D J Grainger
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

6.  A novel neutrophil chemoattractant generated during an inflammatory reaction in the rabbit peritoneal cavity in vivo. Purification, partial amino acid sequence and structural relationship to interleukin 8.

Authors:  B C Beaubien; P D Collins; P J Jose; N F Totty; J Hsuan; M D Waterfield; T J Williams
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

7.  Correlation between Chemokine Receptor CXCR4 Expression and Prognostic Factors in Patients with Prostate Cancer.

Authors:  Seok Jin Jung; Chun Il Kim; Choal Hee Park; Hyuk Soo Chang; Byung Hoon Kim; Mi Sun Choi; Hyea Ra Jung
Journal:  Korean J Urol       Date:  2011-09-28

8.  Stimulation of neutrophil respiratory burst and degranulation by Japanese encephalitis virus-induced macrophage derived factor.

Authors:  N Khanna; S Srivastav; A Mathur; U C Chaturvedi
Journal:  Int J Exp Pathol       Date:  1993-08       Impact factor: 1.925

9.  Eosinophil accumulation induced by human interleukin-8 in the guinea-pig in vivo.

Authors:  P D Collins; V B Weg; L H Faccioli; M L Watson; R Moqbel; T J Williams
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

10.  Comparative responses of human and rabbit interleukin-1 in vivo: effect of a recombinant interleukin-1 receptor antagonist.

Authors:  C von Uexküll; S Nourshargh; T J Williams
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.